The global landscape of renal treatment is switching promptly. With the global rise of Long-term kidney illness (CKD), hypertension, and diabetes, the tension on nephrology departments, specialized dialysis centers, and transplant units has intensified significantly. For B2B companies—which include healthcare system brands of hemodialysis machine